Millendo Therapeutics, Inc.

MLND · NASDAQ
Analyze with AI
12/31/2024
12/31/2020
12/31/2019
12/31/2018
Assets
Cash & Equivalents$30,268$38,174$62,478$73,286
Short-Term Investments$0$0$0$4,385
Receivables$0$314$1,276$2,333
Inventory$0$0$0$0
Other Curr. Assets$1,206$2,413$7,378$3,418
Total Curr. Assets$31,474$40,901$71,132$83,422
Property Plant & Equip (Net)$9,529$2,157$3,331$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$485$351$507$652
Total NC Assets$10,014$2,508$3,838$652
Other Assets$0$0$0$0
Total Assets$41,488$43,409$74,970$84,074
Liabilities
Payables$2,450$1,486$1,495$1,998
Short-Term Debt$7,223$976$1,959$189
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,547$5,525$9,066$7,630
Total Curr. Liab.$14,220$7,987$12,520$9,817
LT Debt$8,142$1,696$2,563$383
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$16$752
Total NC Liab.$8,142$1,696$2,579$1,135
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$22,362$9,683$15,099$10,952
Equity
Pref Stock$0$0$0$0
Common Stock$44$19$18$13
Retained Earnings-$207,106-$245,060-$208,654-$164,086
AOCI$0$452$165$148
Other Equity$226,188$278,315$268,342$237,047
Total Equity$19,126$33,726$59,871$73,122
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$41,488$43,409$74,970$84,074
Net Debt-$14,903-$35,502-$57,956-$72,714